ArticleThe Journal of infection2022

Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis.

Aamir Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.